explore -WSS

explore

author：explore 2025-09-03 03:26:00 - browse：7

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Cuban government calls US nuclear submarine stop a 'provocative escalation'

focus

WSS

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Public health communication lessons from Covid

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Women's World Cup brings attention to abuse in soccer

Sickle cell gene therapy cures need to be accessible in Africa

VC firm RA Capital starts a new synthetic biology incubator

leisure time

explore

leisure time

How to save PrEP access — and even expand it

Superbugs, antibiotic resistance get scrutiny in congress

Hollywood unions extend contract negotiations for actors

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

DIEP, the 'gold standard' of breast reconstruction, is under threat

VC firm RA Capital starts a new synthetic biology incubator

Psychedelics group wrestles with new pharma identity

Companies helping big Covid

In age of alternative facts, a scholarly course on calling out crap

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

hotspot

VC firm RA Capital starts a new synthetic biology incubator

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Superbugs, antibiotic resistance get scrutiny in congress

As the dark side of IVF slowly comes into focus, even more transparency is needed

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Ending health disparities requires full federal government, panel says

explore

focus

focus

explore